Acquisition of APIRx

For personal use only APIRX cannabinoid extraction Intellectual Property Proprietary "Ultrapure" extraction methods have the potential to markedly reduce the cost pharmaceutical (cGMP) grade CBD, THC and Cannabigerol (CBG) to reduce the cost of goods for all Incannex products and to ensure that OTC products are price competitive. Microencapsulation improves water solubility, which improves bioavailability and increases formulation options - addressing challenges around hydrophobicity of cannabinoids. Cannabinoid sugar alcohol patent provides unique possibilities for drug delivery. Potential for out licensing of all technologies. Incannex Shareholder Presentation 23

View entire presentation